Tiziana Life Sciences surges on positive trial data for Covid-19 nasal treatment
Shares in biotechnology company Tiziana Life Sciences (TILS:AIM) surged 21% higher to 180p on Tuesday after positive data from a clinical trial of its nasally administered Covid-19 antibody treatment.
The company said ...
02 February 2021